Growth | Page 75 of 99 | SpiritIndia.com

Disinfectant :: Solvay’s Perestane effective against Clostridium difficile and MRSA

Perestane?, an innovative biocidal product created and developed by Solvay, has been proven to be an effective disinfectant against Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile. These so-called ?superbugs? may cause fatal diseases, and the treatment of patients with most current antibiotics is ineffective. Researchers from the University of Leeds and Leeds General Infirmary (United Kingdom) have recently demonstrated that disinfectants commonly used in hospitals fail to eradicate Clostridium difficile from the premises, and may even promote spore formation.

Arthritis :: New therapeutic hope for degenerative disc disease

For some domestic mammals, including sheep, goats and dogs, the occurrence of degenerative disc disease is extremely rare. Intrigued by this fact and how it might apply to humans, researchers in Toronto, Canada, decided to conduct a gene expression study on intervertebral discs from canines.

Healthcare :: Novartis highlights strong R&D pipeline, plans for multiple new product launches

Novartis unveiled today new data on its promising pipeline amid plans for multiple new product approvals and launches over the next two years. Many of these anticipated approvals are for potentially best-in-class medicines that would advance treatment standards for patients with hypertension, diabetes, cancer and other diseases.

Silicon :: Brilliant growth without gold – Silicon nanowires

Max Planck researchers in Halle present new methods for manufacturing nanowires from silicon.

Prostate Cancer :: Aging gene also protects against prostate cancer development

Cancer researchers have found that a gene that is involved in regulating aging also blocks prostate cancer cell growth. They have shown that the enzyme SIRT1 can block the growth of treatment-resistant prostate cancer cells that overexpress a mutation for the androgen receptor. The scientists hope the newly found connection will aid in better understanding the development of prostate cancer and lead to new drugs against the disease.

Diabetes :: NYU Scripps finding offers new path for treatment of diabetes

Researchers at New York University and the Scripps Research Institute have discovered a new enzyme, GAPDH, which regulates insulin pathways — a finding that offers a new direction for the treatment of diabetes. The research is reported in the most recent issue of the journal Nature Chemical Biology.

Genome :: A giant among minnows – Giant danio can keep growing

Two fish that share much in common genetically appear to have markedly different abilities to grow, a finding that could provide a new way to research such disparate areas as muscle wasting disease and fish farming. Because the zebrafish and giant danio are closely related and the zebrafish’s genome has already been mapped, scientists hope they can more easily identify the genetic keys to the difference in growth potential between them.

Cancer :: Canadian Strategy for Cancer Control – Harper, Canada

Prime Minister Stephen Harper of Canada unveiled a five-year, $260-million national program for fighting cancer in the country on Friday. Harper announced the establishment of the Canadian Partnership Against Cancer — a not-for-profit corporation that will oversee the five-year initiative.

Healthcare :: New private clinics in Nova Scotia

Nova Scotia’s Tory government opened the door for private clinics to provide more public health care in the province with a bill to regulate the private system.

Ecology :: Plant conservation key to ecologic balance

Flora conservation will not only protect Hong Kong’s rare plants, but is also important in maintaining the city’s ecological balance, Conservation Officer Dr Yip Kwok-leung says.